JNap’s Substack
Subscribe
Sign in
Home
Podcast
Notes
Chat
Archive
About
Latest
Top
Discussions
An Update, Two New Ideas, and a Post-Mortem
Oh, and the XBI is back to $100!
Oct 2
•
JNap
3
44:55
September 2025
Four Names I Used To Hate
And now I'm feeling the love?
Sep 24
•
JNap
4
32:47
September Bioevents I'm Watching
And I make predictions too!!
Sep 19
•
JNap
7
54:51
Nuvation Bio - Full Video Analysis
NUVB
Sep 12
•
JNap
7
54:53
Debating IOBT
What to do with IOBT
Sep 10
•
JNap
2
1
37:08
Thoughts on Ideaya Bio (IDYA)
Slides, with a Podcast!!
Sep 8
•
JNap
2
42:14
Conference Call Notes
listened to a bunch of firesides at Citi, Wells Fargo, and Cantor this week. Here are some notes I took.
Sep 5
•
JNap
5
Thoughts on Grace Therapeutics (GRCE)
Will IV Nimodipine become the new standard of care for aSAH?
Sep 5
•
JNap
6
Research Update - Busy Tuesday!!
Thoughts on CYTK, MLYS, ARVN/OLMA, IDYA, UTHR/LQDA, SPRY
Sep 2
•
JNap
3
30:20
August 2025
Bio5C Research Update
Two new "lotto" ideas in the portfolio, providing some more thoughts on VKTX, highlighting why TARS is a top-5 position, and taking a victory lap on…
Aug 28
•
JNap
6
25:07
Portfolio Moves!
We sold these 2 stocks and bought these 3.
Aug 26
•
JNap
3
4
33:00
Thoughts on VKTX (Podcast)
And other ramblings on the obesity market.
Aug 20
•
JNap
7
2
41:03
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts